Federal Rescheduling Reshapes Industry as Markets and States Recalibrate – Business of Cannabis
Comments Off on Federal Rescheduling Reshapes Industry as Markets and States Recalibrate – Business of Cannabis
May 20, 2026
Federal cannabis rescheduling clinical implications extend beyond regulatory headlines to reshape how clinicians approach cannabis medicine research and patient care. This landmark policy shift removes decades-old research barriers while creating new…
Federal Schedule III shift triggers D.C., Maryland cannabis uncertainty – Outlaw Report
Comments Off on Federal Schedule III shift triggers D.C., Maryland cannabis uncertainty – Outlaw Report
May 19, 2026
Federal rescheduling of cannabis to Schedule III would fundamentally change how physicians approach cannabis medicine, moving from state recommendations to federal prescriptions. This regulatory shift creates both opportunities for standardized cannabis…